KAKEHASHI
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
N/A | N/A | Seed | |
$8.0m | Series A | ||
* | $24.0m | Series B | |
N/A | Early VC | ||
$17.1m Valuation: $120m | Early VC | ||
N/A | JPY1.3b | Late VC | |
* | $57.6m | Series C | |
* | $13.8m Valuation: $288m | Series C | |
Total Funding | AUD202m |
Related Content
Recent News about KAKEHASHI
EditKAKEHASHI is a healthcare-focused company based in Japan, dedicated to improving patient satisfaction and driving drug reform. The company operates in the medical experience sector, providing services that support both patients and healthcare providers. KAKEHASHI's primary clients include hospitals, clinics, and pharmaceutical companies. The company leverages workshops and development teams to create solutions that enhance the overall healthcare experience. KAKEHASHI's business model revolves around offering consultancy and support services, which generate revenue through service fees and long-term contracts with healthcare institutions. The company aims to foster a more productive and efficient healthcare environment through continuous improvement and innovation.
Keywords: healthcare, patient satisfaction, drug reform, medical experience, Japan, consultancy, workshops, development teams, hospitals, pharmaceutical companies.